AstraZeneca PLC (AZN)
Company Info
| ISIN | US0463531089 |
|---|---|
| CUSIP | 046353108 |
| Sector | Healthcare |
| Industry | Drug Manufacturers—General |
Highlights
| Market Cap | $212.54B |
|---|---|
| EPS | $1.91 |
| PE Ratio | 35.89 |
| PEG Ratio | 0.89 |
| Revenue (TTM) | $45.81B |
| Gross Profit (TTM) | $35.73B |
| EBITDA (TTM) | $15.01B |
| Year Range | $59.55 - $74.91 |
| Target Price | $81.81 |
| Short % | 0.27% |
| Short Ratio | 1.61 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: AZN vs. MRNA, AZN vs. CTLT, AZN vs. CAH, AZN vs. UNH, AZN vs. VTI, AZN vs. NVO, AZN vs. VONG, AZN vs. NVS, AZN vs. VOO, AZN vs. FSPSX
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in AstraZeneca PLC, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
AstraZeneca PLC had a return of 7.34% year-to-date (YTD) and -3.82% in the last 12 months. Over the past 10 years, AstraZeneca PLC had an annualized return of 11.21%, outperforming the S&P 500 benchmark which had an annualized return of 10.55%.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 7.34% | 6.33% |
| 1 month | 8.11% | -2.81% |
| 6 months | 12.59% | 21.13% |
| 1 year | -3.82% | 24.56% |
| 5 years (annualized) | 16.30% | 11.55% |
| 10 years (annualized) | 11.21% | 10.55% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -1.05% | -2.24% | 5.60% | |||||||||
| 2023 | -0.15% | -6.63% | 2.15% | 4.27% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
AstraZeneca PLC(AZN)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for AstraZeneca PLC (AZN) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
AstraZeneca PLC granted a 2.04% dividend yield in the last twelve months. The annual payout for that period amounted to $1.45 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $1.45 | $1.45 | $1.45 | $1.40 | $1.40 | $1.40 | $1.37 | $1.37 | $1.37 | $1.38 | $1.40 | $1.40 |
Dividend yield | 2.04% | 2.15% | 2.14% | 2.40% | 2.80% | 2.81% | 3.61% | 3.95% | 5.01% | 4.06% | 3.98% | 4.72% |
Monthly Dividends
The table displays the monthly dividend distributions for AstraZeneca PLC. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.99 | $0.00 | |||||||||
| 2023 | $0.00 | $0.99 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.47 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $0.00 | $0.99 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.47 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.95 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2020 | $0.00 | $0.95 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2019 | $0.00 | $0.95 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2018 | $0.00 | $0.93 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2017 | $0.00 | $0.93 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2016 | $0.00 | $0.93 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2015 | $0.00 | $0.94 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2014 | $0.00 | $0.95 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2013 | $0.95 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.00 | $0.00 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the AstraZeneca PLC. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the AstraZeneca PLC was 48.94%, occurring on Mar 9, 2009. Recovery took 977 trading sessions.
The current AstraZeneca PLC drawdown is 4.01%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -48.94% | Oct 26, 2006 | 594 | Mar 9, 2009 | 977 | Jan 24, 2013 | 1571 |
| -43.5% | Mar 4, 2002 | 127 | Aug 30, 2002 | 382 | Mar 9, 2004 | 509 |
| -34.31% | Apr 7, 1998 | 476 | Feb 24, 2000 | 94 | Jul 10, 2000 | 570 |
| -31.27% | Mar 10, 2004 | 221 | Jan 24, 2005 | 229 | Dec 19, 2005 | 450 |
| -29.82% | May 2, 2014 | 653 | Dec 1, 2016 | 272 | Jan 2, 2018 | 925 |
Volatility
Volatility Chart
The current AstraZeneca PLC volatility is 4.69%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |